Intravenous Oxytocin
Intravenous Oxytocin is a pharmaceutical drug with 8 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
2
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
2
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain
Effects Of Intravenous Oxytocin On Peripheral Sensory Afferents Using Microneurography
PROMMO Trial: Oral Misoprostol vs IV Oxytocin
Comparison of the Mean Duration of 3rd Stage of Labour Between Intraumbilical and Intravenous Oxytocin
A Pharmacokinetic Study of Intravenous and Intranasal Oxytocin in Healthy Subjects
Clinical Trials (8)
Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain
Effects Of Intravenous Oxytocin On Peripheral Sensory Afferents Using Microneurography
PROMMO Trial: Oral Misoprostol vs IV Oxytocin
Comparison of the Mean Duration of 3rd Stage of Labour Between Intraumbilical and Intravenous Oxytocin
A Pharmacokinetic Study of Intravenous and Intranasal Oxytocin in Healthy Subjects
Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation
A Study Comparing Vaginal Misoprostol and Intravenous Oxytocin for Induction of Labor
Tearing of Membranes Before Birth - a Comparison Between Two Ways of Induction of Labor Pitocin Opposite Prostaglandin
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8